Evidence map›Paper›PMID 38098074›Full record

ArticleWorld journal of surgical oncology2023

Serum concentrations of proinflammatory biomarker interleukin-6 (IL-6) as a predictor of postoperative complications after elective colorectal surgery.

Vladimír Procházka, Lukáš Lacina, Karel Smetana, Martin Svoboda, Kateřina Skřivanová, Miroslava Beňovská, Jiří Jarkovský, Leoš Křen, Zdeněk Kala

Open access · goldAbstract read
In one paragraph

Article in World journal of surgical oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Observational
  11. Observational
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Vladimír ProcházkaDepartment of Surgery, Faculty of Medicine, University Hospital Brno Bohunice, Masaryk University, Brno, Czech Republic.ORCID http://orcid.org/0000-0001-7747-6072
Lukáš LacinaInstitute of Anatomy, First Faculty of Medicine, Charles University, Prague, Czech Republic.ORCID http://orcid.org/0000-0002-1750-9933
Karel SmetanaInstitute of Anatomy, First Faculty of Medicine, Charles University, Prague, Czech Republic.ORCID http://orcid.org/0000-0002-7878-8403
Martin SvobodaDepartment of Surgery, Faculty of Medicine, University Hospital Brno Bohunice, Masaryk University, Brno, Czech Republic. svoboda.martin2@fnbrno.cz.ORCID http://orcid.org/0000-0001-5607-3450
Kateřina SkřivanováDepartment of Clinical Psychology, University Hospital Brno-Bohunice, Brno, Czech Republic.
Miroslava BeňovskáDivision of Clinical Biochemistry, Department of Laboratory Medicine, University Hospital Brno, Brno, Czech Republic.ORCID http://orcid.org/0000-0002-1188-5698
Jiří JarkovskýFaculty of Medicine, Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic.ORCID http://orcid.org/0000-0002-1400-0111
Leoš KřenDepartment of Pathology, Faculty of Medicine, University Hospital Brno, Masaryk University, Brno, Czech Republic.
Zdeněk KalaDepartment of Surgery, Faculty of Medicine, University Hospital Brno Bohunice, Masaryk University, Brno, Czech Republic.ORCID http://orcid.org/0000-0003-4187-388X
Masaryk University · CZCharles University · CZUniversity Hospital Brno · CZ

Funding

Ministerstvo Zdravotnictví Ceské Republiky,Czechia Conceptual development of research organisation, FNBr, 65269705Operational Programme Research, Development, and Education project National Institute for Cancer Research (Programme EXCELES, ID Project No. LX22NPO5102)Univerzita Karlova v Praze Cooperatio ONCO
6 · The paper itself

Abstract

backgroundThe aim of this prospective study was to evaluate the role of serum IL-6 as a potential predictive biomarker of postoperative complications (POC) in elective colorectal surgery.

methodA total of 115 patients underwent colorectal surgery for malignancy. IL-6 was measured on the first and third postoperative days (POD1, POD3), and C-reactive protein (CRP) was measured on the POD3. POC was analysed in subgroups according to Clavien‒Dindo (CD), antibiotic (ATB) treatment, intensive care unit (ICU) and hospital length of stay. The predictive power of variables for evaluated endpoints was analysed using receiver-operating characteristic (ROC) analysis and described by area under the curve (AUC). ROC analysis was adopted for the identification of optimal cut-offs. Histological analysis was performed to verify IL-6 production by the tumour.

resultsOut of 115 patients who were analysed, 42% had POC. Patients with POC had significantly higher serum levels of IL-6 on POD1 (p < 0.001) and POD3 (p < 0.001). IL-6 early on POD1 as a predictor of antibiotic treatment, ICU stay and hospital stay (AUC 0.818; 0.811; 0.771) did not significantly differ from the AUC of CRP late on POD3 (0.879; 0.838, 0.752). A cut-off IL-6 value of 113 pg/ml on POD1 and 180.5 pg/ml on POD3 in severe complications (CD > 3a) resulted in 75% and 72% sensitivity, 78.6% and 99% specificity, negative predictive value 96.4% and 97% and positive predictive value 29% and 88.9%.

conclusionThe serum level of interleukin-6 can predict severe (CD > 3a) POC early on POD1. On POD3, IL-6 is superior to CRP in terms of high positive predictive power of severe POC. Interestingly, the advantage of IL-6 on POD1 is early prediction of the need for antibiotic treatment, ICU stay and hospital stay, which is comparable to the CRP serum level late on the third POD.

Indexed as

Colorectal SurgeryInterleukin-6Anti-Bacterial AgentsBiomarkersC-Reactive ProteinHumansPostoperative ComplicationsProspective StudiesROC CurveAnti-Bacterial AgentsBiomarkersC-Reactive ProteinIL6 protein, humanInterleukin-6Colorectal surgeryInfectionInterleukin-6Postoperative complications

Identifiers

PMID38098074
PMCPMC10720211
OpenAlexW4389741626

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.